Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers

Diabetes and Metabolism

Volumn 34, Issue 4, 2008, Pages 363-369

  Richard, J L ^a   Sotto, A ^b,c   Jourdan, N ^c   Combescure, C ^c   Vannereau, D ^a   Rodier, M ^c   Lavigne, J P ^b,c  

^a Department of Nutrition and Diabetes   (France)

^b INSERM   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Diabetes mellitus; Diabetic foot; Diabetic foot infection; Healing; Multidrug resistant microorganism; Risk factors; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; HEMOGLOBIN A1C; IMIPENEM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TICARCILLIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; ISCHEMIA; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; OSTEOMYELITIS; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; RISK FACTORS; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

EID: 51849130959     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.02.005     Document Type: Article

References (29)

1. Lipsky B.A. Infectious problems in diabetic patients. In: Bowker J.H., and Pfeifer M.A. (Eds). Levin and O'Neal's the diabetic foot. 6th ed. (2001), Mosby, St Louis 467-480
2. Société de pathologie infectieuse de langue française. Management of diabetic foot infections. Med Mal Infect 37 (2007) 1-25
3. Tentolouris N., Jude E.B., Smirnof I., Knowles E.A., and Boulton A.J. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16 (1996) 767-771
4. Dang C.N., Prassad Y.D.M., Boulton A.J.M., and Jude E.B. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20 (2003) 159-161
5. Valencia I.C., Kirsner R.S., and Kerdel F.A. Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. J Am Acad Dermatol 50 (2004) 845-849
6. Game F.L., Boswell T., Soar C., Houghton E., Treece K.A., Pound M., et al. Outcome of diabetic foot ulcers with and without Staphylococcus aureus (MRSA). Diabet Med 20 (2003) 30
7. Game F., and Jeffcoate W. MRSA and osteomyelitis of the foot in diabetes. Diabet Med 21 (2004) 16-19
8. Harteman-Heurtier A., Robert J., Jacqueminet S., Ha Van G., Golmard J.L., Jarlier V., et al. Diabetic foot ulcer and multidrug-resistant-organisms: risk factors and impact. Diabet Med 21 (2004) 710-715
9. Wagner A., Reike H., and Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infection. Dtsch Med Wochenschr 126 (2001) 1353-1356
10. Trividic-Rumeau M., Bouyssou-Gauthier M.L., Mounier M., Sparsa A., Blaise S., Bédane C., et al. Methicillin-sensible and methicillin resistant Staphylococcus aureus related morbidity in chronic wounds: a prospective study. Ann Dermatol Venereol 130 (2003) 601-605
11. International Working Group on the Diabetic Foot. International consensus on the diabetic foot and practical guidelines on the management and prevention of the diabetic foot. Noordwijkerhout; 2007.
12. Soussy CJ, Carret G, Cavallo JD, and the Antibiotic Susceptibility Testing Committee of the French Society for Microbiology. Antibiotic susceptibility testing. Available from http://www.sfm.asso.fr, French Society for Microbiology, 2007. [Accessed October 05, 2007.]
13. Massin P., Angioi-Duprez K., Bacin F., Cathelineau B., Cathelineau G., Chaine G., et al. Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM. Diabetes Metab 22 (1996) 203-209
14. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 27 (2004) 579-583
15. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003) 3333-3341
16. World Health Organization. Obesity - preventing and managing the global epidemic. Geneva: WHO; 1998.
17. Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39 (2004) 885-910
18. Lavery L.A., Armstrong D.G., Murdoch D.P., Peters E.J.G., and Lipsky B.A. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 44 (2007) 562-567
19. Gadepalli R., Dhawan B., Sreenivas V., Kapil A., Ammini A.C., and Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 29 (2006) 1727-1732
20. Shanker E.M., Mohan V., Premlatha G., Srinivasan R.S., and Usha A.R. Bacterial etiology on diabetic foot infections in South India. Eur J Intern Med 16 (2005) 567-570
21. Selby J.V., and Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care 18 (1995) 509-516
22. Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 19 (1996) 607-612
23. Young B.A., Maynard C., Reiber G., and Boyko E.J. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care 26 (2003) 495-501
24. Mizobuchi S., Minami J., Jin F., Matsushita O., and Okabe A. Comparison of the virulence of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Microbiol Immunol 38 (1994) 599-605
25. Margolis D.A., Allen-Taylor L., Hoffstad O., and Berlin J.A. Diabetic neuropathic foot ulcers? The association of wound size, wound duration, and wound grade on healing. Diabetes Care 25 (2002) 1835-1839
26. Leese G., Schofield C., McMurray B., Libby G., Golden J., MacAlpine R., et al. Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic. Diabetes Care 30 (2007) 2064-2069
27. Margolis D.J., Kantor J., Santana J., Strom B.L., and Berlin J.A. Risk factors for delayed healing of neuropathic diabetic foot ulcers. A pooled analysis. Arch Dermatol 136 (2000) 1531-1535
28. Idris I., Game F., and Jeffcoate W. Does close glycaemic control promote healing in diabetic foot ulcers? Report of a feasibility study. Diabet Med 22 (2005) 1060-1063
29. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282 (1998) 1745-1751